Related Experiment Video

Updated: Jun 24, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

11.8K

Summary and Panel Discussion

Javed Butler1, Jonathan Rich2, Rachel Pessah-Pollack3

  • 1Baylor Scott and White Research Institute, Dallas, Texas, USA; Baylor Scott and White Health, Dallas, Texas, USA; University of Mississippi School of Medicine, Jackson, Mississippi, USA.

JACC. Heart Failure
|June 5, 2024
PubMed

Insights

Sodium-glucose co-transporter 2 (SGLT2) inhibitors are vital for managing heart failure, with or without type 2 diabetes. This video summarizes key findings on their role in heart failure treatment.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Heart failure (HF) is a major cause of morbidity and mortality.
  • Type 2 diabetes (T2D) is a significant risk factor and comorbidity in HF.
  • Emerging evidence highlights the benefits of specific drug classes in HF management.

Purpose of the Study:

  • To summarize the essential points from an enhanced publication on SGLT2 inhibitors in heart failure.
  • To provide expert insights into the clinical application of SGLT2 inhibitors for heart failure patients.
  • To discuss the role of SGLT2 inhibitors in patients with and without type 2 diabetes.

Main Methods:

  • Expert panel discussion summarizing a key publication.
  • Review of clinical evidence and guidelines.
  • Focus on the role of Sodium-glucose co-transporter 2 (SGLT2) inhibitors.

Main Results:

  • SGLT2 inhibitors demonstrate significant benefits in heart failure management.
  • These benefits extend to patients with and without type 2 diabetes.
  • Key mechanisms and clinical implications are discussed.

Conclusions:

  • SGLT2 inhibitors are a cornerstone therapy for heart failure.
  • Consideration of SGLT2 inhibitors is crucial for all eligible heart failure patients.
  • Further research and clinical application are warranted.

Keywords:
SGLT2 inhibitorsdiagnosisheart failureprimary care

More Related Videos

Multimodal Protocol for Assessing Metacognition and Self-Regulation in Adults with Learning Difficulties12:55

Multimodal Protocol for Assessing Metacognition and Self-Regulation in Adults with Learning Difficulties

Published on: September 27, 2020

8.4K
Project-Based Learning Guidelines for Health Sciences Students: An Analysis with Data Mining and Qualitative Techniques13:44

Project-Based Learning Guidelines for Health Sciences Students: An Analysis with Data Mining and Qualitative Techniques

Published on: December 9, 2022

3.5K

Related Concept Videos

Techniques of Therapeutic Communication II: Focusing, Paraphrasing, and Summarizing01:23

Techniques of Therapeutic Communication II: Focusing, Paraphrasing, and Summarizing

Focusing involves centering a conversation on a message's critical elements or concepts. Focusing is valuable if the talk is vague or patients begin to repeat themselves. Sometimes, when patients are asked about their symptoms, they may go off-topic and try to tell their entire life story. Respectfully, the nurse should bring the conversation back into focus.
This therapeutic technique can also be used when a patient brings up pertinent information during a health-related conversation. The...
7.8K
SBAR I: Understanding the Concept01:29

SBAR I: Understanding the Concept

Effective communication among healthcare professionals during hand-off reporting is essential to delivering safe and continuous patient care. Common professional interactions include reports to healthcare team members, hand-off, and transfer reports. Nurses routinely report information to other healthcare team members and also urgently contact healthcare providers to report changes in patient status.
Standardized methods of communication have been developed to ensure that information is...
4.5K
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.4K
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
751
Statistical Analysis: Overview01:11

Statistical Analysis: Overview

When we take repeated measurements on the same or replicated samples, we will observe inconsistencies in the magnitude. These inconsistencies are called errors. To categorize and characterize these results and their errors, the researcher can use statistical analysis to determine the quality of the measurements and/or suitability of the methods.
One of the most commonly used statistical quantifiers is the mean, which is the ratio between the sum of the numerical values of all results and the...
6.6K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K